PharMerica CORP Total Liabilities and Equity
PharMerica CORP had Total Liabilities and Equity of $1.27 billion as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2017-11-09
- 2017-09-30: Liabilities and Equity $1.27B.
- 2017-06-30: Liabilities and Equity $1.24B.
- 2017-03-31: Liabilities and Equity $1.25B.
- 2016-12-31: Liabilities and Equity $1.27B; Liabilities and Equity as first filed $1.30B.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2017-09-30 | $1.27B 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.24B 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $1.25B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.27B 10-Q · filed 2017-11-09 | $1.30B 10-K · filed 2017-02-24 |
| 2016-09-30 | $1.16B 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.20B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.17B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $1.15B 10-K · filed 2017-02-24 | $1.15B 10-K · filed 2016-02-26 |
| 2015-09-30 | $1.06B 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $1.06B 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.04B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.07B 10-K · filed 2016-02-26 | $1.07B 10-K · filed 2015-03-02 |
| 2014-09-30 | $1.05B 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $923.40M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $869.40M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $900.80M 10-K · filed 2015-03-02 | $901.40M 10-K · filed 2014-02-28 |
| 2013-09-30 | $845.10M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $850.30M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $840.90M 10-Q · filed 2013-05-01 | |
| 2012-12-31 | $886.30M 10-K · filed 2014-02-28 | $885.70M 10-K · filed 2013-02-07 |
| 2012-09-30 | $798.20M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $782.30M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $800.40M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $834.00M 10-K · filed 2013-02-07 | $833.40M 10-K · filed 2012-02-09 |
| 2011-09-30 | $787.60M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $823.40M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $759.70M 10-K · filed 2012-02-09 |